Coefficient D_av Is More Sensitive Than Fractional Anisotropy in Monitoring Progression of Irreversible Tissue Damage in Focal Nonactive Multiple Sclerosis Lesions

References

1. ↵
   Simon JH, Jacobs LD, Campion M, et al. Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis: The Multiple Sclerosis Collaborative Research Group. Ann Neurol 1998;43:79–87

   CrossRefPubMedWeb of Science
2. ↵
   van Waesberghe JH, Castelijns JA, Scheltens P, et al. Comparison of four potential MR parameters for severe tissue destruction in multiple sclerosis lesions. Magn Reson Imaging 1997;15:155–162

   CrossRefPubMedWeb of Science
3. Barnes D, Munro PM, Youl BD, Prineas JW, McDonald WI. The longstanding MS lesion: a quantitative MRI and electron microscopic study. Brain 1991;114:1271–1280

   Abstract/FREE Full Text
4. ↵
   Newcombe J, Hawkins CP, Henderson CL, et al. Histopathology of multiple sclerosis lesions detected by magnetic resonance imaging in unfixed postmortem central nervous system tissue. Brain 1991;114:1013–1023

   Abstract/FREE Full Text
5. ↵
   Losseff NA, Webb SL, O’Riordan JI, et al. Spinal cord atrophy and disability in multiple sclerosis: a new reproducible and sensitive MRI method with potential to monitor disease progression. Brain 1996;119:701–708

   Abstract/FREE Full Text
6. Stevenson VL, Leary SM, Losseff NA, et al. Spinal cord atrophy and disability in MS: a longitudinal study. Neurology 1998;51:234–238

   Abstract/FREE Full Text
7. Fox NC, Jenkins R, Leary SM, et al. Progressive cerebral atrophy in MS: a serial study using registered, volumetric MRI. Neurology 2000;54:807–812

   Abstract/FREE Full Text
8. Ge Y, Grossman RI, Udupa JK, et al. Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis. Radiology 2000;214:665–670

   PubMedWeb of Science
9. ↵
   Jagust WJ, Noseworthy JH. Brain atrophy as a surrogate marker in MS: faster, simpler, better? Neurology 2000;54:782–783

   FREE Full Text
10. ↵
    Brex PA, Parker GJ, Leary SM, et al. Lesion heterogeneity in multiple sclerosis: a study of the relations between appearances on T1 weighted images, T1 relaxation times, and metabolite concentrations. J Neurol Neurosurg Psychiatry 2000;68:627–632

    Abstract/FREE Full Text
11. ↵
    van Walderveen MA, Barkhof F, Pouwels PJ, van Schijndel RA, Polman CH, Castelijns JA. Neuronal damage in T1-hypointense multiple sclerosis lesions demonstrated in vivo using proton magnetic resonance spectroscopy. Ann Neurol 1999;46:79–87

    CrossRefPubMedWeb of Science
12. ↵
    Bruck W, Bitsch A, Kolenda H, Bruck Y, Stiefel M, Lassmann H. Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol 1997;42:783–793

    CrossRefPubMedWeb of Science
13. ↵
    van Walderveen MA, Kamphorst W, Scheltens P, et al. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis. Neurology 1998;50:1282–1288

    Abstract/FREE Full Text
14. ↵
    van Walderveen MA, Barkhof F, Hommes OR, et al. Correlating MRI and clinical disease activity in multiple sclerosis: relevance of hypointense lesions on short-TR/short-TE (T1-weighted) spin-echo images. Neurology 1995;45:1684–1690

    Abstract/FREE Full Text
15. ↵
    Simon JH, Lull J, Jacobs LD, et al. A longitudinal study of T1 hypointense lesions in relapsing MS: MSCRG trial of interferon beta-1a: Multiple Sclerosis Collaborative Research Group. Neurology 2000;55:185–192

    Abstract/FREE Full Text
16. ↵
    Le Bihan D, Breton E, Lallemand D, Grenier P, Cabanis E, Laval-Jeantet M. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 1986;161:401–407

    CrossRefPubMedWeb of Science
17. ↵
    Christiansen P, Gideon P, Thomsen C, et al. Increased water self-diffusion in chronic plaques and in apparently normal white matter in patients with multiple sclerosis. Acta Neurol Scand 1993;87:195–199

    PubMedWeb of Science
18. ↵
    Horsfield MA, Lai M, Webb SL, et al. Apparent diffusion coefficient in benign and secondary progressive multiple sclerosis by nuclear magnetic resonance. Magn Reson Med 1996;36:393–400

    CrossRefPubMedWeb of Science
19. ↵
    Nusbaum AO, Lu D, Tang CY, Atlas SW. Quantitative diffusion measurements in focal multiple sclerosis lesions: correlations with appearance on TI-weighted MR images. AJR Am J Roentgenol 2000;175:821–825

    CrossRefPubMedWeb of Science
20. ↵
    Castriota-Scanderbeg A, Tomaiuolo F, Sabatini U, Nocentini U, Grasso MG, Caltagirone C. Demyelinating plaques in relapsing-remitting and secondary-progressive multiple sclerosis: assessment with diffusion MR imaging. AJNR Am J Neuroradiol 2000;21:862–868

    Abstract/FREE Full Text
21. ↵
    Pierpaoli C, Jezzard P, Basser PJ, Barnett A, Di Chiro G. Diffusion tensor MR imaging of the human brain. Radiology 1996;201:637–648

    CrossRefPubMedWeb of Science
22. ↵
    Griffin CM, Chard DT, Ciccarelli O, et al. Diffusion tensor imaging in early relapsing-remitting multiple sclerosis. Mult Scler 2001;7:290–297

    Abstract/FREE Full Text
23. ↵
    Tievsky AL, Ptak T, Farkas J. Investigation of apparent diffusion coefficient and diffusion tensor anisotrophy in acute and chronic multiple sclerosis lesions. AJNR Am J Neuroradiol 1999;20:1491–1499

    Abstract/FREE Full Text
24. ↵
    Filippi M, Cercignani M, Inglese M, Horsfield MA, Comi G. Diffusion tensor magnetic resonance imaging in multiple sclerosis. Neurology 2001;56:304–311

    Abstract/FREE Full Text
25. ↵
    Guo AC, MacFall JR, Provenzale JM. Multiple sclerosis: diffusion tensor MR imaging for evaluation of normal-appearing white matter. Radiology 2002;222:729–736

    CrossRefPubMedWeb of Science
26. ↵
    Werring DJ, Clark CA, Barker GJ, Thompson AJ, Miller DH. Diffusion tensor imaging of lesions and normal-appearing white matter in multiple sclerosis. Neurology 1999;52:1626–1632

    Abstract/FREE Full Text
27. ↵
    Bammer R, Augustin M, Strasser-Fuchs S, et al. Magnetic resonance diffusion tensor imaging for characterizing diffuse and focal white matter abnormalities in multiple sclerosis. Magn Reson Med 2000;44:583–591

    CrossRefPubMedWeb of Science
28. ↵
    Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227–231

    CrossRefPubMedWeb of Science
29. ↵
    Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey: National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996;46:907–911

    Abstract/FREE Full Text
30. ↵
    Calamante F, Porter DA, Gadian DG, Connelly A. Correction for eddy current induced Bo shifts in diffusion-weighted echo-planar imaging. Magn Reson Med 1999;41:95–102

    CrossRefPubMedWeb of Science
31. ↵
    Papadakis NG, Xing D, Houston GC, et al. A study of rotationally invariant and symmetric indices of diffusion anisotropy. Magn Reson Imaging 1999;17:881–892

    CrossRefPubMedWeb of Science
32. ↵
    Charcot J. Histologie de la sclerose en plaques. Gaz Hop (Paris) 1868;41:554–566
33. ↵
    Ferguson B, Matyszak MK, Esiri MM, Perry VH. Axonal damage in acute multiple sclerosis lesions. Brain 1997;120:393–399

    Abstract/FREE Full Text
34. ↵
    Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998;338:278–285

    CrossRefPubMedWeb of Science
35. ↵
    Bitsch A, Schuchardt J, Bunkowski S, Kuhlmann T, Bruck W. Acute axonal injury in multiple sclerosis: correlation with demyelination and inflammation. Brain 2000;123:1174–1183

    Abstract/FREE Full Text
36. ↵
    Lovas G, Szilagyi N, Majtenyi K, Palkovits M, Komoly S. Axonal changes in chronic demyelinated cervical spinal cord plaques. Brain 2000;123:308–317

    Abstract/FREE Full Text
37. ↵
    Truyen L, van Waesberghe JH, van Walderveen MA, et al. Accumulation of hypointense lesions (“black holes”) on T1 spin-echo MRI correlates with disease progression in multiple sclerosis. Neurology 1996;47:1469–1476

    Abstract/FREE Full Text
38. ↵
    Pierpaoli C, Basser PJ. Toward a quantitative assessment of diffusion anisotropy. Magn Reson Med 1996;36:893–906

    CrossRefPubMedWeb of Science
39. ↵
    Ciccarelli O, Werring DJ, Wheeler-Kingshott CA, et al. Investigation of MS normal-appearing brain using diffusion tensor MRI with clinical correlations. Neurology 2001;56:926–933

    Abstract/FREE Full Text
40. ↵
    Werring DJ, Clark CA, Droogan AG, Barker GJ, Miller DH, Thompson AJ. Water diffusion is elevated in widespread regions of normal-appearing white matter in multiple sclerosis and correlates with diffusion in focal lesions. Mult Scler 2001;7:83–89

    Abstract/FREE Full Text
41. ↵
    Nusbaum AO, Tang CY, Wei T, Buchsbaum MS, Atlas SW. Whole-brain diffusion MR histograms differ between MS subtypes. Neurology 2000;54:1421–1427

    Abstract/FREE Full Text
42. ↵
    Cercignani M, Inglese M, Pagani E, Comi G, Filippi M. Mean diffusivity and fractional anisotropy histograms of patients with multiple sclerosis. AJNR Am J Neuroradiol 2001;22:952–958

    Abstract/FREE Full Text
43. ↵
    Narayanan S, Fu L, Pioro E, et al. Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions. Ann Neurol 1997;41:385–391

    CrossRefPubMedWeb of Science
44. ↵
    Allen IV, McKeown SR. A histological, histo-chemical and biochemical study of the macroscopically normal white matter in multiple sclerosis. J Neurol Sci 1979;41:81–91

    CrossRefPubMedWeb of Science
45. ↵
    Newcombe J, Cuzner ML, Roytta M, Frey H. White matter proteins in multiple sclerosis. J Neurochem 1980;34:700–708

    PubMedWeb of Science
46. ↵
    Matthews PM, De Stefano N, Narayanan S, et al. Putting magnetic resonance spectroscopy studies in context: axonal damage and disability in multiple sclerosis. Semin Neurol 1998;18:327–336

    CrossRefPubMedWeb of Science
47. ↵
    De Stefano N, Narayanan S, Francis GS, et al. Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch Neurol 2001;58:65–70

    CrossRefPubMedWeb of Science
48. ↵
    Miller DH, Johnson G, Tofts PS, MacManus D, McDonald WI. Precise relaxation time measurements of normal-appearing white matter in inflammatory central nervous system disease. Magn Reson Med 1989;11:331–336

    PubMedWeb of Science
49. ↵
    Loevner LA, Grossman RI, Cohen JA, Lexa FJ, Kessler D, Kolson DL. Microscopic disease in normal-appearing white matter on conventional MR images in patients with multiple sclerosis: assessment with magnetization-transfer measurements. Radiology 1995;196:511–515

    CrossRefPubMedWeb of Science
50. ↵
    Evangelou N, Konz D, Esiri MM, Smith S, Palace J, Matthews PM. Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis. Brain 2000;123:1845–1849

    Abstract/FREE Full Text
51. ↵
    Bo L, Dawson TM, Wesselingh S, et al. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann Neurol 1994;36:778–786

    CrossRefPubMedWeb of Science